Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Semnur Pharmaceuticals, Inc. (SMNR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Semnur Pharmaceuticals, Inc. (SMNR), most recent 12 months reported: net loss $167.68M. Latest balance sheet on file: liquid cash $39K, total debt $23.05M, net cash -$23.01M. From SEC filings. Others in Pharmaceutical Preparations: SIONNA THERAPEUTICS, INC. · Skye Bioscience, Inc. · SELLAS Life Sciences Group, Inc. · Summit Therapeutics Inc. · SOLIGENIX, INC. · Spruce Biosciences, Inc. · Savara Inc · SYNLOGIC, INC.

Stock screener

Watchlist